Karim Amrane

Years Active: 2020-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Margaux Geier, Renaud Descourt, Romain Corre, Guillaume Léveiller, Régine Lamy, Éric Goarant, Jean-Louis Bizec, Cyril Bernier, Gilles Quéré, Karim Amrane, Elisabeth Gaye, François Lucia, Emilie Burte, Christos Chouaid, Gilles Robinet
Duration of nivolumab for pretreated, advanced non-small-cell lung cancer. Cancer medicine 9 (19) (2020)
Karim Amrane, Margaux Geier, Romain Corre, Hervé Léna, Guillaume Léveiller, Florence Gadby, Régine Lamy, Jean-Louis Bizec, Eric Goarant, Gilles Robinet, Sylvie Gouva, Gilles Quere, Ronan Abgral, Ulrike Schick, Cyril Bernier, Christos Chouaid, Renaud Descourt
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study. Cancer medicine 9 (7) (2020)

Karim Amrane.css-eqlu8i{font-size:small;padding-left:4px;}